Tj Florence
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tj Florence has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Anshul Ratnaparkhi
Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA
3 shared publications - Bayard Wilson
Department of Neurosurgery, University of California, Los Angeles, Los Angeles, California, USA
3 shared publications - David A. Zarrin
David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
3 shared publications - Kirstin Cook
Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, United States
3 shared publications - Abhinav Suri
Department of Radiology, David Geffen School of Medicine at UCLA, Los Angeles, Calif
2 shared publications - Andrew C. Vivas
Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA, USA
2 shared publications
Latest Publications
- Open Access
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e72535
The Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians
Background: Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. Objective: This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. Methods: The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. Results: Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. Conclusions: To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine.
- 4 December 2025
- Published by JMIR Publications Inc. in JMIR AI
- Vol. 4, e72535
Open AccessThe Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians
Background: Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. Objective: This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. Methods: The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. Results: Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. Conclusions: To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine.
- Open Access
- 11 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
The Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians (Preprint)
BACKGROUND Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. OBJECTIVE This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. METHODS The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. RESULTS Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. CONCLUSIONS To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine. CLINICALTRIAL
- 11 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Perceived Roles of AI in Clinical Practice: National Survey of 941 Academic Physicians (Preprint)
BACKGROUND Artificial intelligence (AI) and machine learning models are frequently developed in medical research to optimize patient care, yet they remain rarely used in clinical practice. OBJECTIVE This study aims to understand the disconnect between model development and implementation by surveying physicians of all specialties across the United States. METHODS The present survey was distributed to residency coordinators at Accreditation Council for Graduate Medical Education–accredited residency programs to disseminate among attending physicians and resident physicians affiliated with their academic institution. Respondents were asked to identify and quantify the extent of their training and specialization, as well as the type and location of their practice. Physicians were then asked follow-up questions regarding AI in their practice, including whether its use is permitted, whether they would use it if made available, primary reasons for using or not using AI, elements that would encourage its use, and ethical concerns. RESULTS Of the 941 physicians who responded to the survey, 384 (40.8%) were attending physicians and 557 (59.2%) were resident physicians. The majority of the physicians (651/795, 81.9%) indicated that they would adopt AI in clinical practice if given the opportunity. The most cited intended uses for AI were risk stratification, image analysis or segmentation, and disease prognosis. The most common reservations were concerns about clinical errors made by AI and the potential to replicate human biases. CONCLUSIONS To date, this study comprises the largest and most diverse dataset of physician perspectives on AI. Our results emphasize that most academic physicians in the United States are open to adopting AI in their clinical practice. However, for AI to become clinically relevant, developers and physicians must work synergistically to design models that are accurate, accessible, and intuitive while thoroughly addressing ethical concerns associated with the implementation of AI in medicine. CLINICALTRIAL
- 10 July 2023
- Published by Elsevier in World Neurosurgery
- Vol. 178, e135-e140
Lumbar Spinal Canal Segmentation in Cases with Lumbar Stenosis Using Deep-U-Net Ensembles
- 10 July 2023
- Published by Elsevier in World Neurosurgery
- Vol. 178, e135-e140
Lumbar Spinal Canal Segmentation in Cases with Lumbar Stenosis Using Deep-U-Net Ensembles
- 1 April 2023
- Published by Wolters Kluwer Health in Spine
- Vol. 49 (7) , 506-512
Methylprednisolone Following Minimally Invasive Lumbar Decompression
Study Design.: Prospective randomized. Objective.: Intraoperative methylprednisolone is a common adjunct following microscopic laminectomy/microdiscectomy. The goal of epidural instillation is a rapid symptomatic reduction in irritation of neural elements. There is inconsistent data supporting its use intraoperatively. To understand whether this maneuver results in any clinical effect, we performed a multiyear prospective study. Summary of Background Data.: Previous work has demonstrated equivocal effects on pain with a suggestion of an increased risk of complication. These studies tend to suffer from small sample sizes and short follow-ups. Materials and Methods.: Study obtained IRB approval. During the study period from 2013 to 2019, nearly equivalent numbers of patients who had received steroids during MIS decompressions were followed. Primary outcomes included pain (visual analog scale) and disability [Oswestry Disability Index (ODI)] at 2 weeks and 4 months. Secondary outcomes included complications, readmissions, and reoperation rates during the study period. Results.: Four hundred eighty-six patients were followed for a mean follow-up of 5.17 years. The index case was more likely to be a revision surgery in the steroid group. Across all patients, there was no difference in pain at 2 weeks or 4 months. Disability was reduced at 2 weeks in the steroid group (ODI: 16.71 vs. 21.02, P = 0.04) but not at 4 months. By subgroup analysis, this is largely explained by ODI reduction in patients with high preoperative ODI (13.00 vs. 43.43, P = 0.03). Patients in the steroid cohort were more likely to undergo subsequent spinal surgery during the study period. Conclusion.: Methylprednisolone instillation is associated with a large, transient reduction in ODI for patients with high preoperative ODI; there is no measurable effect on pain. There is equivocal effect on risk of subsequent reoperation. This issue was clarified in peer review but changes did not make it to the Therefore, the technique is likely best reserved for patients with significant preoperative disability.
- 1 April 2023
- Published by Wolters Kluwer Health in Spine
- Vol. 49 (7) , 506-512
Methylprednisolone Following Minimally Invasive Lumbar Decompression
Study Design.: Prospective randomized. Objective.: Intraoperative methylprednisolone is a common adjunct following microscopic laminectomy/microdiscectomy. The goal of epidural instillation is a rapid symptomatic reduction in irritation of neural elements. There is inconsistent data supporting its use intraoperatively. To understand whether this maneuver results in any clinical effect, we performed a multiyear prospective study. Summary of Background Data.: Previous work has demonstrated equivocal effects on pain with a suggestion of an increased risk of complication. These studies tend to suffer from small sample sizes and short follow-ups. Materials and Methods.: Study obtained IRB approval. During the study period from 2013 to 2019, nearly equivalent numbers of patients who had received steroids during MIS decompressions were followed. Primary outcomes included pain (visual analog scale) and disability [Oswestry Disability Index (ODI)] at 2 weeks and 4 months. Secondary outcomes included complications, readmissions, and reoperation rates during the study period. Results.: Four hundred eighty-six patients were followed for a mean follow-up of 5.17 years. The index case was more likely to be a revision surgery in the steroid group. Across all patients, there was no difference in pain at 2 weeks or 4 months. Disability was reduced at 2 weeks in the steroid group (ODI: 16.71 vs. 21.02, P = 0.04) but not at 4 months. By subgroup analysis, this is largely explained by ODI reduction in patients with high preoperative ODI (13.00 vs. 43.43, P = 0.03). Patients in the steroid cohort were more likely to undergo subsequent spinal surgery during the study period. Conclusion.: Methylprednisolone instillation is associated with a large, transient reduction in ODI for patients with high preoperative ODI; there is no measurable effect on pain. There is equivocal effect on risk of subsequent reoperation. This issue was clarified in peer review but changes did not make it to the Therefore, the technique is likely best reserved for patients with significant preoperative disability.
- 15 August 2022
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 91 (4) , e104
Commentary: Prognostic Significance of Baseline Frailty Status in Traumatic Spinal Cord Injury
- 15 August 2022
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 91 (4) , e104
Commentary: Prognostic Significance of Baseline Frailty Status in Traumatic Spinal Cord Injury